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Original Article
Safety of insulin tolerance test for the assessment of growth
hormone deficiency in children
Saira Waqar Lone,1 Yasir Naqi Khan,2 Farah Qamar,3 Irum Atta,4 Mohsina Noor Ibrahim,5 Jamal Raza6
Department of Paediatrics, National Institute of Child Health,1,2,4-6 Aga Khan University Hospital,3 Karachi.
Abstract
Objective: To determine the safety of insulin tolerance test (ITT) for assessing growth hormone (GH)
deficiency in children. 
Methods: This hospital based study was conducted at the National Institute of Child Health, Karachi from
1st November 2008 till 30th October 2009. All children suspected of growth hormone deficiency, were
included after excluding all other causes of short stature. Verbal informed consent was taken from the
parents. Children less than 2 years of age, weighing less than 10 kg, untreated/ inadequately treated
hypothyroidism or Addison's disease, epilepsy, having history of hypoglycaemic fits or cardiac disease were
excluded. All children were subjected to the international standard protocol of ITT and their samples of
growth hormone and blood sugars were drawn. Complications during the procedure like hypoglycaemia,
hypothermia, loss of consciousness, fits, vomiting and failure to achieve hypoglycaemia were recorded.
Insulin tolerance test was performed on a total of 168 subjects. The data was entered in SPSS version 17
for analysis.
Results: A total of 168 children were subjected to the ITT. Four of them were abandoned as they could
not achieve hypoglycaemia despite repeating the dose of insulin. Results were analyzed on 164
children whose mean age was 10 ± 3.5 years. There were 96 (58%) males and 68(41%) females. Over
all 79.8% children achieved hypoglycaemia. None of the subjects developed any complication (fits,
loss of consciousness,) or required intravenous glucose during the test and it was completed in all
children with close monitoring. The results showed that there was a significant effect of time after
insulin administration on both the blood glucose level (BG) and growth hormone (GH) levels. The blood
glucose level decreased rapidly after administration of insulin and was lowest 30 minutes after
injection and showed an increasing trend in subsequent readings, becoming almost equal to the
baseline value 120 min after injection. From the study group 111 (66%) children were diagnosed as
having growth hormone deficiency, 52 (31.3%) were normal and 1(0.6%) had growth hormone
insensitivity.
Conclusion: ITT in children was found to be a safe and reliable test but can be potentially dangerous
and requires very close monitoring and supervision and should be performed in a center with
experienced staff.
Keywords: Insulin tolerance test, hypoglycaemia, growth hormone deficiency (JPMA 61:153; 2011).
Introduction
The exact incidence of growth hormone deficiency
(GHD) in children is unknown; several studies estimate it to
range between 1 per 4,000 to 1 per 10,000 children presenting
with short stature.1 Children with growth hormone deficiency
present in the neonatal period with hypoglycaemia,
prolonged jaundice and micropenis. In childhood the
presentation is with short stature, slowing of growth
(decreased growth velocity) and delayed puberty. The
diagnosis of growth hormone deficiency in children is
complicated requiring both clinical and laboratory
investigations and is a challenging task. The pulsatile nature
of growth hormone secretion causes a random measurement
of serum growth hormone which is not helpful in the
diagnosis of growth hormone deficiency.2,3 Provocative tests
are needed to evaluate the growth hormone reserve and the
commonly used ones are; Insulin induced hypoglycaemia
(ITT), clonidine stimulation, arginine stimulation, glucagon,
growth hormone releasing hormone stimulation tests and two
abnormal tests are used to confirm impaired GH secretion.4
There is unfortunately no consensus in children
regarding the gold standard test for diagnosis of growth
hormone deficiency. The commonly used tests in children are
ITT, L-dopa and clonidine. The ITT has been shown to be
safe in children when performed following an international
protocol in experienced centers with strict observation for
side effects. Galloway et al in his large review of 10 years
data regarding the safety of ITT reported no serious side
effects during the test.5
In adults the ITT has been considered as the gold
standard in assessing growth hormone and cortisol reserve.4
An audit of ITT in adults by Lange et al showed that no
serious side effects occurred during it and concluded it to be
a safe test when performed in experienced hands.6
The exact incidence of growth hormone deficiency in
our country is unknown but small scale studies in children
with short stature have been conducted and show it to range
between 6.1% and 14%.7,8 A local study in which ninety nine
children were subjected to ITT, 47 were found to be growth
hormone deficient.9 Because of the lack of a gold standard,
various tests are being used in our country but local data
regarding the safety of these tests are not available. 
There is a pediatric endocrine clinic at the National
Institute of Child Health which caters to endocrine problems
of children from all over the city. ITT is regularly performed
in this hospital for the diagnosis of GH deficiency but safety
of the test in the local population has not been established. The
study was undertaken to establish the safety of ITT for the
diagnosis of growth hormone deficiency in our population.
The outcome measures used were complications
occurring during the test as a result of hypoglycaemia.
(seizures, loss of consciousness) requiring administration of
glucose.
Material and Methods
This study was conducted at National Institute of
Child Health, Karachi from 1st December 2008 till 1st
December 2009.All children suspected of growth hormone
deficiency were included. Those children who were less
than 2 years of age, weighed less than 10 kg, untreated/
inadequately treated hypothyroidism or Addison's disease,
epilepsy, hypoglycaemic fits or cardiac disease were
excluded. The ITT was performed according to the standard
international protocol after taking consent from parents. The
test was carried out in the presence of a doctor and a trained
staff nurse. The child on whom the test was to be performed
was admitted on the evening prior to the test and fasted over
night and only water was allowed. Rapid acting insulin,
glucometer with strips, 10% dextrose water and injection
hydrocortisone 100mg were present at the bedside at the
time of the test. The child was told to bed rest for 30 min
before the test. A large bore intravenous cannula was
inserted which was connected to an extension tube for
repeated sampling.
The blood glucose was checked at baseline via a
glucometer and rapid acting insulin given at a dose of
0.1IU/kg intravenously and all the blood glucose during the
ITT were checked on glucometer. Blood samples for serum
blood glucose and serum growth hormone were drawn at 0,
30, 60, 90 and 120 minutes and sent to the laboratory.
If the blood glucose at baseline was less than 45
mg/dl, no insulin was given and the next sample of 60 min
drawn. If blood glucose was less than 40 mg/dL, then a
glucose drink with a volume of 30 mI was given. If blood
glucose did not increase within 30 minutes or further
decreased, a further 30 ml was given orally. If the child could
not tolerate oral glucose then intravenous glucose 200 mg/kg
(10% dextrose, 2 ml/kg) over 3 minutes was given. If
panhypopituitarism was suspected (for example in children
who had radiotherapy) 100 mg of hydrocortisone was
administered intravenously as a bolus. Following the test the
child was provided a meal and discharged from the hospital
only after an adequate meal had been taken, and the blood
glucose was at least 72mg/dL.
The procedure of ITT is as follows:
1. At 0 minute: Check blood glucose, if less than 45
mg/dl, no insulin is given. If blood sugar> 45mg/dl, 0.01u/kg
of intravenous insulin is given. Draw samples of blood
glucose and Growth hormone(GH) for laboratory,
2. 30 minutes: Check blood glucose and collect
samples of blood glucose and GH for laboratory.
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3. 60 minutes: Check blood glucose and collect
samples of blood glucose and GH for laboratory.
4. 90 minutes: Check blood glucose and collect
samples of blood glucose and GH for laboratory.
5. 120 minutes: Check blood glucose on glucometer
and collect samples of blood glucose and GH for laboratory.
Allow the child orally. Keep him under observation for 4
hours and then discharge. 
Hypoglycaemia was defined as blood glucose of less
than 45 mg/dl, but some children developed clinical
hypoglycaemia (sweating) and their samples were drawn at
that time even if blood glucose was not less than 45 mg/dl.
Growth hormone deficiency was diagnosed if the value of
peak serum growth hormone was less than 10 µg/l and value
above 10 µg/l excluded growth hormone deficiency.
The samples for serum blood glucose were analyzed
by biochemistry auto analyzer on Dimension RxL and serum
growth hormone was analyzed by ELISA on Immulite 1000
at the laboratory at National Institute of Child Health.
Statistical analysis:
The mean and standard deviation of age, blood
glucose levels and growth hormone measured at 30 minute
intervals during the ITT were calculated. The frequency of
children developing hypoglycaemia (blood sugar <45 mg/dl)
was calculated.
The serial levels of blood glucose and growth
hormone at baseline, 30, 60, 90 and 120 minutes after
administration of 0.1U/kg insulin were analyzed using
repeated measures ANOVA. Differences were considered
significant at P <0.05.
Results
A total of 168 children were subjected to the ITT.
Four of them were abandoned as they could not achieve
hypoglycaemia despite repeating the dose of insulin. In 26
(15.8%) children the dose of insulin had to be repeated.
Results were analyzed on 164 children, five (3%) of them
had blood sugar level of <45 at baseline and they were not
given insulin. Blood glucose and GH levels in these
children were monitored at regular intervals without insulin
administration. In the remaining 159 children, blood
glucose and GH levels were monitored every 30 minutes
after insulin injection. 
Mean age of the subjects was 10 ± 3.5 years. There
were 96 (58%) males and 68(41%) females. Overall 131
(79.8%) children developed hypoglycaemia (<45 mg/dl).
Maximum number of children (35%) developed
hypoglycaemia at 30 min and the percentage of children
developing hypoglycaemia decreased in subsequent readings
at 60, 90 and 120 minutes (Table). Seven (4.2%) children
developed clinical hypoglycaemia and had sweating and
malaise although their blood glucose reading on glucometer
was above 45mg/dL.
Children were closely monitored for complications.
None developed significant complications of hypoglycaemia
such as seizures, loss of consciousness/drowsiness or
hypothermia <35ºC and the test was completed in all subjects
with close monitoring. None of the children required
intravenous glucose after developing hypoglycaemia or had
tremors/tachycardia during the test. The test was successfully
completed in all children with no serious side effect and after
4 hours of observation they were sent home.
Using repeated measures ANOVA, for the growth
hormone levels and blood sugar, showed that there was a
significant effect of time after insulin administration on
both the blood glucose and growth hormone levels. There
was a significant difference between blood glucose at
baseline and the subsequent three values of blood glucose
(BG) at 30, 60 and 90 minutes (BG2, BG3 and BG4)
recorded. There was no significant difference between
baseline blood glucose and BG 5 (at 120 min) (Figure-1).
The blood glucose level decreased rapidly after
administration of insulin and was lowest 30 minutes after
injection and showed an increasing trend in subsequent
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Table: Frequency of Hypoglycaemia during ITT.
Blood glucose timings No of children with blood sugar
less than 45mg/dl.
BG1 ( 0 min) 5 (3%)
BG2 ( 30 min) 58 (35.3%)
BG3 (60 min) 35 (21.3%)
BG4 (90 min) 20 (12.1%)
BG5 (120 min) 13 (7.9%)
Total 131(79 .8%) 
BG: blood glucose.
Figure-1: Mean blood sugar levels (with 95% CI) after administration of insulin.
readings, becoming equal to the baseline value 120 min
after injection. The values of growth hormone were
maximum 30 and 60 min after administration of insulin,
coinciding with the peak of hypoglycaemia. The value of
growth hormone almost reached its baseline value 120
minutes after insulin injection (Figure-2).
In the study group of 164 children, 111 (66%) were
diagnosed as having growth hormone deficiency, 52 (31.3%)
were normal and 1(0.6%) had growth hormone insensitivity
with raised GH levels. 
Discussion
The insulin tolerance test is a very specialized test
which can only be performed in centers with trained personal
and fully equipped to deal with any untoward incident. In our
country arginine and clonidine are not available for
diagnosing growth hormone deficiency and L Dopa is not
commonly performed; ITT is an important and valuable test
for diagnosing growth hormone deficiency but is not
frequently performed and very few centers are performing it
currently. Studies have shown ITT to have good diagnostic
yield when compared with other studies but can lead to
complications if not performed by trained staff. Our study has
also shown it to have good diagnostic value as almost all
children achieved hypoglycaemia and no side effects were
encountered. 
Growth hormone is a prolonged and quite expensive
treatment with the distress of a daily injection; therefore
definitive diagnosis of growth hormone deficiency is very
important.10 Studies regarding safety or documenting any
adverse effects of the ITT are limited in children; but a
better precision of ITT for diagnosing growth hormone
deficiency has been reported. It is still being used as a
definitive test in many centers over the world but some
centers perform at least two different tests before
confirming growth hormone deficiency. In this study we
tried to document carefully any serious complications
occurring during the test due to low blood glucose and
except sweating and hunger none of the children
experienced any other symptoms. Side effects with ITT are
very rare, not even documented in the elderly also. There
had been some reports related to fatalities of ITT but this
was due to high concentrations of glucose given to correct
glucose.11 However, inducing hypoglycaemia with
intravenous insulin must always be seen as potentially
dangerous and so very cautious patient selection by
excluding those with seizure disorders or those with
significant cardiac disease is mandatory.12,13
Very limited studies regarding the safety of ITT are
available and fortunately in our study, no complications were
observed. A similar conclusion has also been made by
Galloway who reviewed his data of ITT in a large sample of
550 children over a ten year period and documented no
serious adverse effects.5
A recent local study reviewing cost effectiveness of
the samples of growth hormone during the ITT reported a
cost effectiveness of 29 % if the 120 minute sample was not
considered and they concluded that the 0 till 90 minute
samples were sufficient to diagnose GH deficiency.[9] In
our study group we found that almost 8% children achieved
hypoglycaemia at 120 minutes and they would have been
missed had the 120 minute sample been abandoned.
Probably larger studies from different centers on this aspect
would help to prove this and reach to a conclusion as it is
very difficult to subject a child to ITT and then also not
reach a definitive diagnosis. 
ITT is therefore a safe test if performed in a center
fully equipped and with experienced staff. 
Conclusion
ITT was found to be a safe and reliable test if
performed appropriately following a standard protocol with
strict monitoring for side effects. It needs to be conducted in
a center with expertise, staff and equipment to treat any
serious problem encountered.
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